XRAY Stock Cash Flow Statements

DENTSPLY SIRONA Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

DENTSPLY SIRONA Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-06-30	2012-03-31

cash flows from operating activities:
net income	-44,000,000	19,000,000	-428,000,000	-495,000,000	-4,000,000	17,000,000	72,000,000	-266,000,000	85,000,000	-23,000,000	-15,000,000	-1,077,000,000	73,000,000	69,000,000	102,000,000	103,000,000	99,000,000	117,000,000	98,600,000	54,200,000	-95,900,000	-139,900,000	102,500,000	85,000,000	36,400,000	39,200,000	1,500,000	27,500,000	-1,121,000,000	81,100,000	-1,050,300,000	59,700,000	92,300,000	105,900,000	125,300,000	84,481,000	44,065,000	63,954,000	72,920,000	80,865,000	88,691,000	72,573,000	82,041,000	54,228,000
adjustments to reconcile net income to net cash from operating activities:
depreciation	34,000,000	34,000,000	34,000,000	35,000,000	32,000,000	32,000,000	33,000,000	35,000,000	33,000,000	31,000,000	29,000,000	31,000,000	30,000,000	29,000,000	30,000,000	30,000,000	32,000,000	32,000,000	38,200,000	39,300,000	32,300,000	32,200,000	31,600,000	31,200,000	35,500,000	34,900,000	29,500,000	34,600,000	35,500,000	33,300,000	31,200,000	30,900,000	31,900,000	31,600,000	23,500,000	22,818,000	19,471,000	19,311,000	21,370,000	19,802,000	21,327,000	20,416,000	20,148,000	20,209,000
amortization of intangible assets	54,000,000	45,000,000	54,000,000	54,000,000	54,000,000	54,000,000	52,000,000	53,000,000	53,000,000	53,000,000	50,000,000	51,000,000	53,000,000	55,000,000	55,000,000	55,000,000	56,000,000	56,000,000	49,400,000	48,800,000	46,600,000	47,200,000	46,700,000	47,400,000	47,300,000	48,200,000	48,200,000	49,600,000	50,200,000	49,900,000	46,600,000	45,200,000
goodwill asset impairment
indefinite-lived intangible asset impairment					0	6,000,000	0				6,000,000								300,000	0	0	38,700,000	0	0	0	5,300,000	0	0
deferred income taxes	-137,000,000	1,000,000	-116,000,000	-9,000,000	-2,000,000	-9,000,000	-23,000,000	-24,000,000	-62,000,000	-21,000,000	-8,000,000	-207,000,000	1,000,000	-14,000,000	-9,000,000	-5,000,000	-3,000,000	-3,000,000	-11,300,000	-20,300,000	-24,300,000	-8,100,000	2,500,000	-21,500,000	-12,400,000	-6,000,000	35,900,000	-27,100,000	-54,000,000	-16,800,000	-44,000,000	9,800,000	-31,500,000	9,900,000	-80,400,000	10,503,000	8,525,000	20,172,000	-11,505,000	-23,532,000	3,229,000	-11,793,000	-8,122,000	3,690,000
stock-based compensation expense	9,000,000	10,000,000	4,000,000
other non-cash expense	10,000,000	9,000,000		-2,000,000	19,000,000	19,000,000		-7,000,000	27,000,000	9,000,000		9,000,000	27,000,000	2,000,000		-8,000,000	3,000,000	17,000,000				8,100,000																		-8,058,000			-5,316,000	1,079,000
changes in operating assets and liabilities:
accounts and notes receivable-trade	0	-31,000,000	85,000,000	-67,000,000	59,000,000	27,000,000	-27,000,000	7,000,000	-23,000,000	-15,000,000	42,000,000	-10,000,000	19,000,000	34,000,000	-11,000,000	-81,000,000	-28,000,000	11,000,000	-23,100,000	-119,600,000	215,400,000	53,300,000	-70,700,000	-19,200,000	-38,000,000	36,500,000	-1,600,000	2,100,000	-64,500,000	87,500,000	-44,300,000	46,200,000	-10,100,000	-15,700,000	-67,100,000	12,097,000	-29,751,000	-10,246,000	-22,920,000	6,869,000	-36,115,000	-36,209,000	-15,864,000	-25,597,000
inventories	-21,000,000	-26,000,000	15,000,000	9,000,000	-2,000,000	-5,000,000	51,000,000	-13,000,000	-2,000,000	-30,000,000	-1,000,000	-45,000,000	-54,000,000	-41,000,000	19,000,000	-5,000,000	-27,000,000	-50,000,000	50,200,000	74,800,000	56,300,000	-57,300,000	62,100,000	-30,100,000	13,200,000	-31,500,000	63,400,000	-14,000,000	-4,600,000	-64,700,000	-11,300,000	-38,300,000	-3,800,000	36,100,000	8,600,000	5,974,000	11,557,000	-7,431,000	-15,180,000	-4,584,000	-18,620,000	-22,080,000	-13,028,000	-34,006,000
prepaid expenses and other current assets	27,000,000	-1,000,000	-23,000,000	32,000,000	57,000,000	-28,000,000	-6,000,000	-12,000,000	-23,000,000	-17,000,000	13,000,000	-7,000,000	-22,000,000	-17,000,000	-8,000,000	-5,000,000	5,000,000	-27,000,000	-8,200,000	17,200,000	60,200,000	-27,200,000	16,600,000	-11,500,000	24,200,000	-16,300,000	20,200,000	-21,600,000	-20,100,000	-5,600,000	-50,100,000	-9,200,000	-14,200,000	8,400,000	-16,900,000	-8,832,000	7,467,000	-5,635,000	-5,751,000	-227,000	22,279,000	4,085,000	4,617,000	-24,072,000
other noncurrent assets	-3,000,000	4,000,000	1,000,000	0	0	-6,000,000	8,000,000	-3,000,000	0	-1,000,000	14,000,000	-7,000,000	-9,000,000	3,000,000	2,000,000	-4,000,000	5,000,000	-13,000,000	-7,000,000	2,100,000	12,700,000	-6,800,000	5,900,000	-21,300,000	2,100,000	4,800,000	-2,400,000	-2,600,000	-4,800,000	-2,900,000	15,600,000	-14,400,000	3,300,000	4,000,000	-2,400,000	3,380,000	3,231,000	-2,511,000	1,465,000	147,000	1,443,000	-598,000	-19,451,000	15,954,000
accounts payable	-24,000,000	14,000,000	-24,000,000	5,000,000	17,000,000	-28,000,000	24,000,000	5,000,000	-1,000,000	-14,000,000	-10,000,000	-9,000,000	30,000,000	19,000,000	-7,000,000	-11,000,000	-11,000,000	-17,000,000	41,700,000	24,000,000	-59,800,000	-28,900,000	56,600,000	1,700,000	-20,900,000	-11,300,000	-3,000,000	16,600,000	-2,600,000	-3,900,000	-13,900,000	23,400,000	-15,300,000	12,700,000	1,200,000	6,262,000	-309,000	5,247,000	8,047,000	-13,956,000	-215,000	-10,928,000	-12,848,000	11,528,000
accrued liabilities	9,000,000	-44,000,000	-22,000,000	61,000,000	-28,000,000	-50,000,000	7,000,000	21,000,000	-13,000,000	-31,000,000	-4,000,000	45,000,000	6,000,000	-53,000,000	37,000,000	51,000,000	71,000,000	-81,000,000	55,600,000	66,000,000	-43,500,000	-95,100,000	80,800,000	45,600,000	9,000,000	-90,100,000	7,400,000	-2,500,000	72,800,000	-77,400,000	16,800,000	-36,000,000	13,600,000	4,400,000	-15,500,000	22,278,000	18,580,000	-36,258,000	-21,901,000	4,327,000	3,938,000	-7,559,000	17,942,000	-21,186,000
income taxes	-43,000,000	-12,000,000	53,000,000	-6,000,000	-7,000,000	-2,000,000	-5,000,000	28,000,000	3,000,000	-37,000,000	-56,000,000	39,000,000	-1,000,000	3,000,000	6,000,000	19,000,000	0	-8,000,000	-29,100,000	4,700,000	-21,600,000	7,000,000	-27,200,000	22,400,000	-23,300,000	12,300,000	-1,100,000	41,700,000	-14,400,000	-14,100,000	16,000,000	-31,400,000	32,800,000	-40,400,000	-1,100,000	-7,126,000	4,414,000	-4,488,000	23,423,000	47,214,000	3,526,000	-21,196,000
other noncurrent liabilities	-58,000,000	-15,000,000	-24,000,000	8,000,000	1,000,000	-13,000,000	-3,000,000	4,000,000	23,000,000	6,000,000	9,000,000	1,000,000	-2,000,000	-7,000,000	-10,000,000	12,000,000	-5,000,000	13,000,000	-1,400,000	-5,000,000	-5,800,000	-2,800,000	-6,800,000	2,800,000	1,500,000	300,000	-13,000,000	2,200,000	-10,700,000	5,000,000	9,100,000	-1,400,000	6,300,000	400,000	7,000,000	4,362,000	3,925,000	5,813,000	-1,716,000	795,000	-27,347,000	33,447,000	19,131,000	-15,535,000
net cash from operating activities	48,000,000	7,000,000	87,000,000	141,000,000	208,000,000	25,000,000	160,000,000	134,000,000	104,000,000	-21,000,000	142,000,000	109,000,000	173,000,000	93,000,000	222,000,000	172,000,000	214,000,000	49,000,000	263,500,000	207,100,000	175,100,000	-10,700,000	299,300,000	159,100,000	145,100,000	29,300,000	202,200,000	125,600,000	116,900,000	55,100,000	126,200,000	82,500,000	152,900,000	187,400,000	700,000	159,755,000	145,614,000	65,631,000	64,565,000	126,398,000	95,782,000	36,086,000	83,442,000	19,953,000
cash flows from investing activities:
capital expenditures	-32,000,000	-19,000,000	-51,000,000	-43,000,000	-52,000,000	-34,000,000	-40,000,000	-37,000,000	-33,000,000	-39,000,000	-32,000,000	-32,000,000	-41,000,000	-44,000,000	-41,000,000	-35,000,000	-36,000,000	-30,000,000	-27,000,000	-21,200,000	-13,200,000	-25,600,000	-36,000,000	-23,400,000	-29,600,000	-33,900,000	-51,900,000	-49,400,000	-45,400,000	-35,800,000	-33,700,000	-31,100,000	-31,200,000	-27,000,000	-20,800,000	-18,266,000	-17,191,000	-16,243,000	-25,322,000	-27,349,000	-22,119,000	-24,032,000	-24,344,000	-18,642,000
free cash flows	16,000,000	-12,000,000	36,000,000	98,000,000	156,000,000	-9,000,000	120,000,000	97,000,000	71,000,000	-60,000,000	110,000,000	77,000,000	132,000,000	49,000,000	181,000,000	137,000,000	178,000,000	19,000,000	236,500,000	185,900,000	161,900,000	-36,300,000	263,300,000	135,700,000	115,500,000	-4,600,000	150,300,000	76,200,000	71,500,000	19,300,000	92,500,000	51,400,000	121,700,000	160,400,000	-20,100,000	141,489,000	128,423,000	49,388,000	39,243,000	99,049,000	73,663,000	12,054,000	59,098,000	1,311,000
cash received on derivative contracts	0	1,000,000					0	35,000,000	2,000,000	2,000,000	3,000,000	5,000,000	4,000,000	1,000,000	1,000,000				200,000	300,000																				-4,000
cash paid on derivative contracts			0	-3,000,000	0	-9,000,000													-100,000	29,600,000																				-49,000
proceeds from sale of property, plant, and equipment	0	1,000,000														1,000,000						700,000		3,600,000
net cash from investing activities	-34,000,000	-17,000,000	-57,000,000	-47,000,000	-50,000,000	-43,000,000	-20,000,000	-2,000,000	-30,000,000	-37,000,000	-29,000,000	-26,000,000	-40,000,000	-43,000,000	-39,000,000	-40,000,000	-176,000,000	-103,000,000	-1,101,600,000	-23,800,000	34,900,000	-15,500,000	-28,700,000	-15,200,000	-11,800,000	-12,700,000	-48,300,000	-45,500,000	-114,300,000	-45,200,000	-150,800,000	-41,100,000	-379,700,000	-18,100,000	504,400,000	36,179,000	-14,432,000	-8,547,000	-28,842,000	-25,703,000	-63,465,000	-72,723,000	-38,308,000	-20,199,000
cash flows from financing activities:
cash paid for treasury stock			0	-100,000,000			-150,000,000	0	0	-150,000,000					-110,000,000	0	0	-90,000,000	0	0	0	-140,000,000	-100,000,000	-100,000,000			0	0			-73,600,000	-77,900,000	-94,700,000	-171,200,000	-428,800,000	-13,725,000	-13,966,000	-85,009,000	-40,395,000	-10,103,000			-7,971,000	-30,869,000
proceeds from 364-day bridge loan	0	435,000,000
repayment of 364-day bridge loan
(repayments) proceeds on other short-term borrowings
cash dividends paid	-32,000,000	-32,000,000	-31,000,000	-33,000,000	-33,000,000	-29,000,000	-30,000,000	-29,000,000	-30,000,000	-27,000,000	-26,000,000	-27,000,000	-27,000,000	-24,000,000	-24,000,000	-24,000,000	-22,000,000	-22,000,000	-22,100,000	-21,900,000	-21,900,000	-22,100,000	-22,200,000	-19,600,000	-19,600,000	-19,500,000	-19,500,000	-19,400,000	-19,900,000	-19,800,000	-20,100,000	-18,000,000	-18,100,000	-18,500,000	-10,100,000	-10,260,000	-10,224,000	-9,416,000	-8,979,000	-8,967,000	-9,019,000	-7,909,000	-7,859,000	-7,847,000
proceeds from long-term borrowings																				100,000								0	200,000	100,000	-100,000	3,000,000	760,800,000	0	79,900,000									4,571,000
repayments on long-term borrowings	0	-2,000,000	-80,000,000	-2,000,000	-3,000,000	-3,000,000	-1,000,000	-5,000,000			0	0	0	-2,000,000	0							-800,000	0	-116,600,000	-132,700,000	-1,900,000	-100,000	-8,900,000	-200,000	-200,000	-1,200,000	-5,400,000	-375,700,000	0	-127,500,000	-8,868,000	-89,000	-100,143,000
cash paid for deferred financing costs	-10,000,000	-3,000,000
other financing activities	0	-3,000,000	-6,000,000	0	-5,000,000	-5,000,000	-3,000,000	-2,000,000	-1,000,000	-4,000,000	-6,000,000	-7,000,000	-1,000,000	-7,000,000	-25,000,000	-3,000,000	0	-8,000,000
net cash from financing activities	-68,000,000	123,000,000	-38,000,000	-79,000,000	-171,000,000	-14,000,000	-128,000,000	-109,000,000	-87,000,000	17,000,000	-161,000,000	-6,000,000	-152,000,000	-10,000,000	-122,000,000	-179,000,000	-25,000,000	-53,000,000	-14,300,000	-23,900,000	658,100,000	-129,900,000	-95,800,000	-160,800,000	-110,300,000	-99,200,000	-78,600,000	-82,400,000	-69,400,000	-19,400,000	-78,900,000	-67,600,000	237,100,000	-177,800,000	-472,800,000	-55,490,000	-138,053,000	-100,457,000	-55,477,000	-109,214,000	-29,039,000	13,603,000	-55,034,000	-12,380,000
effect of exchange rate changes on cash and cash equivalents	15,000,000	13,000,000	-16,000,000	2,000,000	1,000,000	-11,000,000	13,000,000	-9,000,000	-10,000,000	-6,000,000	-5,000,000	-21,000,000	7,000,000	-5,000,000	-3,000,000	-4,000,000	1,000,000	-13,000,000	18,300,000	3,500,000	5,100,000	-12,900,000	4,000,000	-7,100,000	1,700,000	-1,600,000	1,200,000	-3,900,000	-11,000,000	6,000,000	8,600,000	5,600,000	8,800,000	-3,000,000	6,200,000	-477,000	2,724,000	-7,647,000	623,000	2,150,000	-2,454,000	-895,000	-4,236,000	2,844,000
net increase in cash and cash equivalents	-39,000,000	126,000,000					25,000,000	14,000,000	-23,000,000	-47,000,000	-53,000,000	56,000,000	-12,000,000	35,000,000	58,000,000	-51,000,000			-834,100,000	162,900,000											-94,900,000	-20,600,000	19,100,000	-11,500,000	38,500,000								-14,136,000	-9,782,000
cash and cash equivalents at beginning of period	0	272,000,000	0	0	0	334,000,000	0	0	0	365,000,000	0	0	0	339,000,000	0	0	0	438,000,000	100,000	0	0	404,900,000	0	0	0	309,600,000	0	0	0	320,600,000	0	383,900,000	0	0	284,600,000	-39,000	0	151,639,000	74,954,000	0	0	80,132,000	0	77,128,000
cash and cash equivalents at end of period	-39,000,000	398,000,000	-24,000,000	17,000,000	-12,000,000	291,000,000	25,000,000	14,000,000	-23,000,000	318,000,000	-53,000,000	56,000,000	-12,000,000	374,000,000	58,000,000	-51,000,000	14,000,000	318,000,000	-834,000,000	162,900,000	873,200,000	235,900,000	178,800,000	-24,000,000	24,700,000	225,400,000	76,500,000	-6,200,000	-77,800,000	317,100,000	-94,900,000	363,300,000	19,100,000	-11,500,000	323,100,000	139,928,000	-4,147,000	100,619,000	55,823,000	-6,369,000	824,000	56,203,000	-14,136,000	67,346,000
non-cash investing activities:
property, plant and equipment in accounts payable at end of period	3,000,000	22,000,000
exchange of inventory for naming and other rights	0	14,000,000
(repayments) proceeds on short-term borrowings		-272,000,000
supplemental disclosures of cash flow information:
interest paid, net of amounts capitalized		13,000,000
goodwill impairment							0				0								400,000	0	0	156,600,000					0	0
intangible asset impairment
equity in earnings from unconsolidated affiliates																																										1,779,000	-1,329,000	4,248,000
other non-cash income																			-9,300,000	-1,000,000			-7,900,000	4,300,000	-8,900,000	-7,800,000		900,000			19,900,000	-14,400,000	-9,900,000	-28,100,000	-3,400,000	3,725,000	-5,720,000	-8,005,000	-3,405,000			-3,912,000
gain on disposal of property, plant and equipment																						200,000
cash received on sale of non-strategic businesses or product lines															1,000,000	0	8,000,000	19,000,000					0	0
other investing activities			-7,000,000	0			0	0			0	1,000,000
net borrowings on short-term borrowings
income taxes paid, net of refunds
change in accounts payable related to capital expenditures
goodwill and intangible asset impairments
proceeds on short-term borrowings				56,000,000	20,000,000	23,000,000		-75,000,000	-55,000,000	198,000,000		26,000,000	-125,000,000	163,000,000				30,000,000
net decrease in cash and cash equivalents				17,000,000	-12,000,000	-43,000,000												-120,000,000				-169,000,000		-24,000,000	24,700,000	-84,200,000		-6,200,000	-77,800,000	-3,500,000							-4,147,000	-51,020,000	-19,131,000	-6,369,000	824,000	-23,929,000
stock based compensation expense					12,000,000	11,000,000	13,000,000	2,000,000	14,000,000	17,000,000	12,000,000	14,000,000	22,000,000	11,000,000	-6,000,000	22,000,000	19,000,000	13,000,000	10,800,000	16,500,000	10,200,000	9,500,000	16,400,000	15,400,000	25,200,000	9,200,000	5,900,000	5,300,000	500,000	9,300,000	11,100,000	10,800,000
changes in operating assets and liabilities, net of acquisitions:
fixed asset impairment										4,000,000									600,000				0	200,000
restructuring and other costs							-6,000,000	-3,000,000	-6,000,000	48,000,000
gain on sale or disposal of non-strategic businesses and product lines
cash paid for acquisitions of businesses and equity investments, net of cash acquired															0	-7,000,000	-149,000,000	-92,000,000	-1,076,000,000				100,000				0	0	-123,800,000	-6,700,000
proceeds from sale of property, plant and equipment																			300,000	0						300,000	2,900,000	2,400,000	900,000	3,000,000	300,000	1,600,000	500,000	4,000,000	400,000	-3,000	212,000	91,000	168,000	883,000	991,000	1,218,000	299,000	166,000
net borrowings (repayments) on short-term borrowings
proceeds from exercised stock options											0	0	1,000,000	5,000,000	4,000,000	2,000,000	12,000,000	33,000,000	5,000,000	600,000	1,600,000	3,800,000	30,000,000	2,400,000	56,600,000	19,800,000		8,900,000	5,600,000	8,300,000	16,000,000	29,400,000	6,400,000	13,000,000	7,400,000	8,603,000	4,532,000	14,065,000
proceeds from long-term borrowings, net of deferred financing costs											-1,000,000	2,000,000	0	5,000,000	1,000,000	2,000,000	9,000,000	4,000,000					0	117,200,000	800,000	900,000
adjustments to reconcile net (loss)/income to net cash from operating activities:
payments on terminated derivative instruments
gain on sale of non-strategic businesses and product lines																		-13,000,000
cash paid for accelerated share repurchase												0	0	-150,000,000
(gain) loss on sale on non-strategic businesses and product lines
exchange of inventory for naming rights
(gain) loss on sale of non-strategic businesses and product lines																-1,000,000
proceeds (repayments) on short-term borrowings																141,000,000						30,800,000
cash paid for acquisition of noncontrolling interest of consolidated subsidiary
deferred financing costs																				0
cost of products sold
selling, general, and administrative expense
research and development expense
total stock based compensation expense
related deferred income tax benefit
amortization of deferred financing costs																		2,000,000	1,600,000	1,600,000	1,100,000	700,000	600,000	700,000	700,000	700,000	700,000	700,000	600,000	700,000	600,000	700,000	1,500,000	1,000,000	1,100,000	1,123,000	1,088,000	1,089,000	1,142,000	1,250,000	1,296,000	1,296,000	1,195,000	1,196,000
definite-lived intangible asset impairment																							0
restructuring and other costs - non-cash																			4,200,000	1,300,000	2,600,000	1,900,000	900,000	400,000	5,100,000	9,700,000	3,300,000	10,100,000	5,800,000	3,300,000	400,000	600,000	900,000	700,000	2,600,000	-8,014,000	40,982,000	4,832,000
gain on sale of equity security																											0	0	0	-44,100,000
loss on disposal of property, plant and equipment																			300,000	100,000			700,000	2,300,000			1,900,000	2,100,000	100,000	500,000	100,000	300,000	1,300,000			119,000
gain on divestiture of noncontrolling interest																							0	0	0	-8,700,000
loss on sale on non-strategic businesses and product lines
purchases of short term investments
liquidation of short term investments
expenditures for identifiable intangible assets																											0	-200,000	-2,000,000	-3,300,000	-1,100,000	-4,800,000						-178,000	-1,305,000	-86,000	-758,000	-205,000	-42,000	-146,000
proceeds from the sale of equity security
cash paid for acquisition of noncontrolling interests of consolidated subsidiaries
cash paid for contingent consideration on prior acquisitions																			-1,000,000	-300,000	-1,100,000	-1,600,000	-2,500,000	-100,000	0	-30,600,000																	0	-1,781,000
loss on sale of non-strategic businesses and product lines																								-500,000
repayments on short-term borrowings																				0						-67,900,000
repayments of long-term borrowings																				-100,000																			-75,174,000					-5,171,000
stock option expense
rsu expense
purchase of short term investments
cash paid on sale of non-strategic businesses or product lines
cash received on derivatives contracts																						9,400,000		7,500,000	4,300,000	22,700,000		1,800,000			2,900,000	2,400,000	2,000,000	5,000,000	5,700,000	8,133,000	5,674,000	8,593,000
purchase of short-term investments																									500,000	-800,000					-2,200,000	-100,000							-1,144,000
purchase of company owned life insurance policies
net (repayments) borrowings on short-term borrowings
cash paid on derivatives contracts																												0	0	-2,400,000			-12,100,000	-100,000	-3,500,000	10,000	0	-810,000
liquidation of short-term investments
proceeds from sale of equity security																												0
increase in short-term borrowings																											-63,900,000	-63,000,000	195,100,000	-7,800,000	100,000	1,300,000	-44,100,000	-1,500,000	-2,100,000	-32,470,000	-126,747,000	160,117,000
(gain) loss on disposal of property, plant and equipment																										-100,000
cash paid on sale of business or product line																										-1,000,000
stock option income tax benefit																																				-1,178,000	-8,441,000	-381,000	-69,000	-1,140,000	-519,000	-603,000	-1,284,000	-3,879,000
proceeds from the sale of businesses
cash assumed in sirona merger																																	0	0	522,300,000
proceeds from exercise of stock options																																							4,149,000	17,137,000	17,635,000	13,578,000	5,583,000	14,483,000
excess tax benefits from stock based compensation
schedule of non-cash investing activities:
merger financed by common stock																																	0	0	6,256,200,000
income taxes paid
purchase of company-owned life insurance policies																																	0	0	-1,700,000								0	-1,577,000
other non-cash expense/																														14,000,000
cash paid for acquisitions of businesses and equity investments
purchases of short term time deposits
proceeds from redemption of long-term corporate bonds
payments on long-term borrowings
cash assumed in merger
cash and deposits paid for acquisitions of businesses and equity investments, net of cash acquired
cash received from sale of business or product line																																	3,600,000	0	2,400,000
cash and deposits paid for acquisitions of businesses, net of cash acquired																																-9,100,000
amortization																																	44,300,000	43,800,000	21,800,000	10,954,000	10,940,000	10,906,000	12,569,000	11,266,000	11,500,000	11,934,000	12,650,000	15,364,000
share-based compensation expense																																	12,000,000	12,600,000	4,800,000	7,670,000	6,935,000	4,895,000	5,786,000	6,004,000	6,589,000	5,434,000	6,807,000	4,222,000
excess tax benefits from share-based compensation																																	-2,500,000	-400,000	-8,400,000	1,178,000	8,441,000	381,000	69,000	1,140,000	519,000	603,000	1,284,000	3,879,000
equity in net income from unconsolidated affiliates																																				-10,841,000	8,174,000	4,367,000
cash paid for acquisitions of businesses, net of cash acquired																																	-341,400,000	0	-400,000	5,000				0	0	-3,939,000
proceeds from redemption of corporate bonds
cash paid for acquisition of noncontrolling interests of consolidated subsidiary																																				52,000	0	-80,452,000	-33,000	0	0	-8,960,000
equity income from unconsolidated affiliates																																							290,000
cash received on derivatives																																							864,000	1,673,000
cash paid on derivatives																																							-2,103,000	-824,000
net change in short-term borrowings																																							64,886,000	-31,661,000	24,317,000	16,133,000	-46,336,000	11,155,000
restructuring and other costs - noncash																																								-727,000			940,000	1,165,000
equity in (earnings) income from unconsolidated affiliates																																								83,000
payments on settlements of net investment hedges																																										-45,765,000
interest received on derivatives with an other-than-insignificant financing element																																										464,000
interest paid on derivatives with an other-than-insignificant financing element																																										-306,000
net interest expense on derivatives with an other-than-insignificant financing element																																											335,000	800,000
income taxes payable																																											-5,122,000	10,545,000
payment on terminated derivative instruments
net interest payments on derivatives with an other-than-insignificant financing element																																											-335,000	-800,000

We provide you with 20 years of cash flow statements for DENTSPLY SIRONA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DENTSPLY SIRONA stock. Explore the full financial landscape of DENTSPLY SIRONA stock with our expertly curated income statements.

The information provided in this report about DENTSPLY SIRONA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.